Human medicines European public assessment report (EPAR): Durveqtix, fidanacogene elaparvovec, Date of authorisation: 24/07/2024, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 1 August 2024 - 12:40

Human medicines European public assessment report (EPAR): Durveqtix, fidanacogene elaparvovec, Date of authorisation: 24/07/2024, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/durveqtix

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters